Re-programming pullulan for targeting and controlled release of doxorubicin to the hepatocellular carcinoma cells
- 1 May 2017
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 103, 104-115
Abstract
No abstract availableKeywords
Funding Information
- Progetto Startegico UNIPD (C98C13002740005)
This publication has 40 references indexed in Scilit:
- Polymer conjugates for focal and targeted delivery of drugsPolymers for Advanced Technologies, 2013
- Epidemiology of Viral Hepatitis and Hepatocellular CarcinomaGastroenterology, 2012
- Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour?European Journal of Cancer, 2012
- Ferritin light chain and squamous cell carcinoma antigen 1 are coreceptors for cellular attachment and entry of hepatitis B virusInternational Journal of Nanomedicine, 2012
- SERPINB3 induces epithelial–mesenchymal transitionThe Journal of Pathology, 2010
- Hydrolytic Stability of Hydrazones and OximesAngewandte Chemie International Edition, 2008
- Surface expression of squamous cell carcinoma antigen (SCCA) can be increased by the preS1(21–47) sequence of hepatitis B virusJournal of General Virology, 2004
- Squamous Cell Carcinoma Antigen 1-mediated Binding of Hepatitis B Virus to Hepatocytes Does Not Involve the Hepatic Serpin Clearance SystemJournal of Biological Chemistry, 2003
- Body distribution profile of polysaccharides after intravenous administrationDrug Delivery, 1993
- Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virusCell, 1986